Seller record · Telehealth service

LVNG RX

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The treatment pages say protocols are prepared by partner compounding pharmacies in the United States, and the terms refer to the pharmacy only in general terms. 1 more criterion also fails; see the table below.

At a glance

LVNG RXTelehealth service

6/8criteria passed
Price
Semaglutide from $90 a month (was $249, struck through); tirzepatide from $149 (was $299)
Sells
compounded semaglutide injection, compounded tirzepatide injection, and 5 more
FDA letters
None on file
Visit LVNG RXSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth platform selling compounded semaglutide and tirzepatide injections, a GLP-1 microdose program and an oral GLP-1, plus compounded tesamorelin, sermorelin and NAD+, with care from independent licensed providers. Care starts with a short assessment, and the partner compounding pharmacies are not named.

Operating entity LVNG RX LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSLVNG RX's semaglutide product page; LVNG RX's website; LVNG RX's terms
S2Prescription gatingPASSLVNG RX's website; LVNG RX's peptides page; LVNG RX's terms
S3Pharmacy identificationFAILLVNG RX's semaglutide product page; LVNG RX's tesamorelin product page; LVNG RX's terms
S4Compounding disclosurePASSLVNG RX's website; LVNG RX's peptides page
S5Analytical documentationFAILLVNG RX's semaglutide product page; LVNG RX's NAD+ product page; LVNG RX's terms
S6Business addressPASSLVNG RX's contact page; LVNG RX's privacy page; LVNG RX's terms
S7Price disclosurePASSLVNG RX's website; LVNG RX's peptides page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEach consultation is reviewed and authorized by an independent US-licensed provider, and the site says all clinical evaluations and prescription decisions are made solely by independent licensed practitioners.Source: LVNG RX's semaglutide product page; LVNG RX's website; LVNG RX's terms.
S2PASSThe eligibility buttons open the seller's own assessment, and the peptides page lists a short assessment first and a provider review second, with every order approved only if right for the buyer. The home page says nothing is charged if the buyer is not approved, and the terms refund an order the provider declines.Source: LVNG RX's website; LVNG RX's peptides page; LVNG RX's terms.
S3FAILNo filling pharmacy is named. The treatment pages say protocols are prepared by partner compounding pharmacies in the United States, and the terms refer to the pharmacy only in general terms.Source: LVNG RX's semaglutide product page; LVNG RX's tesamorelin product page; LVNG RX's terms.
S4PASSThe footer of every page states that compounded medications are not FDA-approved and that the FDA has not verified their safety, efficacy or quality, and the home page adds that compounded semaglutide and tirzepatide are not the same as the brand drugs.Source: LVNG RX's website; LVNG RX's peptides page.
S5FAILNo certificate of analysis or lot document is published on the treatment pages, the peptide pages, the terms or the privacy policy.Source: LVNG RX's semaglutide product page; LVNG RX's NAD+ product page; LVNG RX's terms.
S6PASSLVNG RX LLC at 254 Chapman Rd, Suite 208 #27645, Newark, DE 19702, printed as the clinic address on the contact page and as the mailing address in the privacy policy. The terms name Delaware law.Source: LVNG RX's contact page; LVNG RX's privacy page; LVNG RX's terms.
S7PASSCompounded semaglutide injection from $90 a month beside a struck-through $249, and compounded tirzepatide injection from $149 a month beside a struck-through $299, each including the provider visit, prescription and delivery. The GLP-1 microdose from $99 a month and the oral GLP-1 from $179. Tesamorelin from $249 a month, sermorelin from $199 and NAD+ from $179.Source: LVNG RX's website; LVNG RX's peptides page.
S8PASSNo FDA warning letter names LVNG RX or LVNG RX LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, GLP-1 microdose, GLP-1 oral, tesamorelin, sermorelin, NAD+.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells tesamorelin

Visit LVNG RX

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.